Clinical Trials Sponsored by Hangzhou Adcoris Biopharmacy Co., Ltd

Total 679 results

Hangzhou Adcoris Biopharmacy Co., Ltd

Not yet recruiting

Study of ACR246 in Advanced Solid Tumors

Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd

Enrolling by invitation

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

HER2-positive Advanced Solid Tumor

China
WestVac Biopharma Co., Ltd.
WestVac Biopharma (Guangzhou) Co., Ltd.

Recruiting

A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

COVID-19

China
GenEros Biopharma Hangzhou Ltd

Recruiting

Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation

Advanced Solid Tumors

China
Hangzhou Converd Co., Ltd.

Recruiting

Safety of Recombinant Human IL-21 Oncolytic Vaccinia Virus Injection（hV01) in Advanced Tumors

Advanced Solid Tumors

China
HJB (Hangzhou) Co., Ltd.

Recruiting

TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density

Osteoporosis

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Kanglin Biotechnology (Hangzhou) Co., Ltd.

Not yet recruiting

A Phase I/II Clinical Study of the KL003 Cell Injection in β-Thalassemia Major Participants

Transfusion-dependent Beta-Thalassemia

China
Hangzhou GluBio Pharmaceutical Co., Ltd.

Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Non-Hodgkin Lymphoma

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Mild to Moderate COVID-19

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors (CSG-1827-101)

Advanced Solid Tumors

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System

Aortic Dissection Aneurysm

China
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors

Solid Tumors

China
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real World Study on Fabulous® Thoracic Aortic Stent System for Stanford B Aortic Dissection

Aortic Dissection

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG1906 for CLDN18.2-Positive Solid Tumors (CSG-1906-101)

Locally Advanced Unresectable or Metastatic Solid Tumors

China
Hangzhou Sciwind Biosciences Co., Ltd.

Recruiting

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

RSV Infection

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

United States
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

COVID-19 Infection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)

Juxtarenal Abdominal Aortic Aneurysm

China
Hangzhou Sumgen Biotech Co., Ltd.

Active, not recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

Relapsed or Refractory Multiple Myeloma | Hematological Malignancy

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Type 2 Diabetes Mellitus | T2DM

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Weight Management

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease

China
Hangzhou Broncus Medical Co., Ltd.

Completed

Safety and Effectiveness of Disposable Pulmonary Surgical Markers in the Localization of Pulmonary Nodules

Lung Cancer

China
Acea Bio (Hangzhou) Co., Ltd.

Unknown

Safety Study of FLP Injection to Treat Tumor Patients

Advanced Cancer

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

Aortic Arch Aneurysm

China
Hangzhou GluBio Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloid Malignancy

China
Hangzhou Sciwind Biosciences Co., Ltd.

Recruiting

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Healthy Volunteers

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs (TARA)

Rheumatoid Arthritis

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

DragonFly EU Pivotal Study

Mitral Valve Insufficiency
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real-World Study on Distal Aortic Remodeling for Stanford Type B Aortic Dissection With Fabulous Thoracic Aortic Stent System

Aortic Dissection

China
Hangzhou Broncus Medical Co., Ltd.

Recruiting

Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD

COPD

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)

Aortic Aneurysm and Dissection

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.

Lymphoma | Hematological Malignancy

United States
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Entry Tear Repair :The First in Man Study of Endopatch System

Chronic Stanford B Type Aortic Dissection Proximal Tear

China
Hangzhou Valgen Medtech Co., Ltd

Recruiting

Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation

Mitral Regurgitation Functional

China
Hangzhou Endonom Medtech Co., Ltd.

Active, not recruiting

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

Aortic Arch Aneurysm

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

Atopic Dermatitis

China
Hangzhou Broncus Medical Co., Ltd.

Completed

Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors (BRONC-RFⅡ)

Lung Neoplasms | Pulmonary Metastasis

China
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Active, not recruiting

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

Locally Advanced/Metastatic HER2 Positive Solid Tumors

China, United States
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Phase Ia Study of XW001 in Healthy Adult Subjects

Respiratory Syncytial Virus Infections

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Treatment of Vein Stenosis or Occlusion With the Oblique Stent

Iliac Vein Stenosis | Iliac Vein Occlusion

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Dragonfly-M Early Feasibility Study

Mitral Regurgitation

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection

Aortic Dissection Type B

China
Hangzhou Valgen Medtech Co., Ltd

Unknown

Safety and Performance Study of the MitralStitch Repair System.

Mitral Regurgitation

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Not yet recruiting

A Study of Efficacy and Safety of TLL-018 in CSU Participants

Chronic Spontaneous Urticaria
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
Hangzhou DAC Biotechnology Co., Ltd.

Not yet recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

Advanced Solid Tumors | Hematological Malignancies
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2918 For Advanced Malignant Tumors

Advanced Malignant Tumors

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

China

Clinical Trials Sponsored by Hangzhou Adcoris Biopharmacy Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations